NCT00420264View on ClinicalTrials.gov

ThermaChoice III Under Local Sedation in the Office Setting

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

May 31, 2009

Conditions
Heavy Uterine Bleeding
Interventions
DEVICE

Uterine Ablation

Uterine Ablation in the office setting to see if the procedure is tolerated w/o sedation

Trial Locations (1)

49506

Grand Valley Gynecologists, PC, Grand Rapids

All Listed Sponsors
collaborator

Ethicon, Inc.

INDUSTRY

lead

Female Pelvic Medicine & Urogynecology Institute of Michigan

OTHER

NCT00420264 - ThermaChoice III Under Local Sedation in the Office Setting | Biotech Hunter | Biotech Hunter